A recent study found that CRMP4 expression mediated by the activation of VEGF signaling facilitated gastric tumor growth and metastasis, which may have clinical implications associated with a reduced survival rate in gastric cancer patients [27]. This evidence concerns the gene DPYSL3 and gastric neoplasm.